MoonLake Immunotherapeutics (MLTX) P/E (2022 - 2026)
MoonLake Immunotherapeutics (MLTX) P/E from Jun 30, 2022 to Jul 21, 2026. The TTM MoonLake Immunotherapeutics (MLTX) P/E is -5.60. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of MoonLake Immunotherapeutics (MLTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.60 | +34.55% |
| 2025 | -4.16 | -89.68% |
| 2024 | -40.32 | -39.09% |
| 2023 | -66.19 | +289.65% |
| 2022 | -16.99 | N/A |
Comparison MoonLake Immunotherapeutics (MLTX) P/E with competitors
MoonLake Immunotherapeutics (MLTX) P/E is -5.60.